Clinical aspects and pathophysiology of diuretic-induced hyponatremia.
D000367:Age Factors; D000368:Aged; D001581:Benzothiadiazines; D001834:Body Water / Q000502:physiology; D001835:Body Weight; D004232:Diuretics / Q000009:adverse effects*; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D007010:Hyponatremia / Q000139:chemically induced* / Q000503:physiopathology / Q000628:therapy; D007049:Iatrogenic Disease; D007177:Inappropriate ADH Syndrome / Q000150:complications; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000378:metabolism; D011379:Prognosis; D012306:Risk; D012737:Sex Factors; D012964:Sodium / Q000097:blood; D012965:Sodium Chloride / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects; D014667:Vasopressins / Q000378:metabolism
D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D014667:Vasopressins; D012965:Sodium Chloride; D005665:Furosemide; D012964:Sodium; D011188:Potassium